Lomedeucitinib
4-[(3-methylsulfonyl-2-pyridinyl)amino]-6-[[(2R)-spiro[2.2]pentane-2-carbonyl]amino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
Molecular Identity
Lomedeucitinib
4-[(3-methylsulfonyl-2-pyridinyl)amino]-6-[[(2R)-spiro[2.2]pentane-2-carbonyl]amino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
PubChem CID: 138620496
2D Structure
Properties
C18H20N6O4S
Molecular Formula
419.50
Molecular Weight
g/mol
419.1455
Exact Mass
Da
0.6
XLogP
Drug-like (Lipinski: < 5)
151
TPSA
May have limited oral absorption
3
H-Bond Donors
8
H-Bond Acceptors
765
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Lomedeucitinib2328068-29-5BMS-986322EYQ7KA55XABMS-986322-014-((3-methylsulfonylpyridin-2-yl)amino)-6-(((2R)-spiro(2.2)pentane-2-carbonyl)amino)-N-(trideuteriomethyl)pyridazine-3-carboxamide4-[(3-methylsulfonylpyridin-2-yl)amino]-6-[[(2R)-spiro[2.2]pentane-2-carbonyl]amino]-N-(trideuteriomethyl)pyridazine-3-carboxamideRefChem:1088548Lomedeucitinib (USAN)LOMEDEUCITINIB [USAN]N-(Methyl-d3)-4-[[3-(methylsulfonyl)-2-pyridinyl]amino]-6-[[(1R)-spiro[2.2]pent-1-ylcarbonyl]amino]-3-pyridazinecarboxamidelomedeucitinib [INN]CHEMBL5314608SCHEMBL20985262SCHEMBL30617380
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lomedeucitinib
Loading drug network...